CEWIT2023 Conference Speakers

Breakout Session Speakers

CEWIT2020 features a strong program of speakers who are experts in their field, and who will share their cutting-edge research and ideas with attendees. The talks will center on the five major fields which are penetrating our business and personal lives: Machine Learning, Artificial intelligence, Blockchain, Computational Medicine, and Cybersecurity. This year they will also cover containment and mitigation of pandemic events by using artificial intelligence and information technology.

Ambassador Ido Aharoni

Ambassador Ido Aharoni

Global Distinguished Professor, Principal, NYU, Emerson Rigby Ltd.

James Xiaojiang Du, PhD

James Xiaojiang Du, PhD

Professor & Director of Security and Networking (SAN) Lab, Temple University

Kevin Eykholt, PhD

Kevin Eykholt, PhD

Researcher, IBM Research

Moncef Gabbouj, MS, PhD

Moncef Gabbouj, MS, PhD

Professor & Director, NSF IUCRC Center for Visual and Decision Informatics, Finland-Site; Tampere University- Faculty of Information Technology and Communication Sciences

Mike Grace, PhD

Mike Grace, PhD

Director of Product Security, Mojo Vision

Song Han, PhD

Song Han, PhD

Assistant Professor, MIT

Daniel Holewienko

Daniel Holewienko

Executive Director, Big Data and Business Intelligence, Henry Schein, Inc.

Arie Kaufman, PhD

Arie Kaufman, PhD

Distinguished Professor & Chief Scientist, Stony Brook University

Anthony Kelly

Anthony Kelly

Data Scientist, Northrop Grumman Mission Systems

Tong Liu, PhD

Tong Liu, PhD

Assistant Professor at the School of Computer Engineering and Science, Shanghai University

Xuan Liu, PhD

Xuan Liu, PhD

Director of Innovation, IBM Watson Health

Cecil Lynch, MD, MS

Cecil Lynch, MD, MS

Chief Medical Information Officer, Accenture

Maurie McInnis

Maurie McInnis

President, Stony Brook University

Brian Merrill

Brian Merrill

Managing Director, Deloitte Forensic Data Analytics Practice

Dejan Milojicic,  PhD

Dejan Milojicic, PhD

Distinguished Technologist, Hewlett Packard Labs

Sharon Nachman, MD

Sharon Nachman, MD

Professor of Pediatrics, Associate Dean for Research, Stony Brook University Hospital

Satoshi Nagata

Satoshi Nagata

Manager, Network innovation laboratories, NTT DOCOMO, INC.

Nicholas Nilan

Nicholas Nilan

Director, Public Sector Product Management, Verizon

Kimberly Noel, MD

Kimberly Noel, MD

Stony Brook Medicine Telehealth Director, Stony Brook University Hospital

Huamin Qu, PhD

Huamin Qu, PhD

Professor, Hong Kong University of Science and Technology

Bryan Reimer, PhD

Bryan Reimer, PhD

Research Scientist, MIT

Milutin Stanacevic, PhD

Milutin Stanacevic, PhD

Associate Professor, Stony Brook University

Bruce Swett, PhD

Bruce Swett, PhD

Chief Artificial Intelligence Architect & NG Fellow, Northrop Grumman Mission Systems

Yair Tauman, PhD

Yair Tauman, PhD

Leading Professor and Director, Stony Brook University

Tao Wang, PhD

Tao Wang, PhD

Associate Professor, Peking University

Bin Xiao, PhD

Bin Xiao, PhD

Associate Professor, Hong Kong Polytechnic University

Ye Zhao, PhD

Ye Zhao, PhD

Professor, Kent State University

 

Venture Capital Session Speakers

Technology commercialization is seldom a direct linear path. On the one hand, inherent to the metabolism of this activity is funding, be it forms of venture capital, self-funding, or by customers and/or licensees. Meanwhile, prevailing business environments and market profiles naturally intervene in charting an enterprise's directions. Through its two Segments, the International CEWIT Conference Venture Capital Breakout session aims to provide information valuable to anyone managing this process.

Venture Capital Trends Session

Segment 1 is the international Venture Capital Trends Panel. This distinguished Panel is composed of lead investors (alphabetically) from India, Israel, the UK, and USA. Discussion will focus on what is influencing the flow of venture capital now as to its directions and relative quantities. CEWIT Conference attendees will be invited to submit their questions.

Michael Lane

Michael Lane, Moderator

Director, Long Island Capital Alliance

Stav Erez

Stav Erez

Partner, Labs/02

Neil Callahan

Neil Callahan

Co-Founder and Managing Director, Pilot Growth Equity

Rajan Luthra

Rajan Luthra

Head of Special Projects, Reliance Industries

Funded Company Update Session

The Funded Company Update Session is a series of Update Presentations by growing early phase companies representing a spectrum of external funding cases from the minimal through Series B. Their presentations will provide examples of how to put investment funding to productive use, how to apply sound business judgment to skillful adaptation to changing market conditions, and will stand out as examples of exciting technologies. Time permitting, CEWIT Conference attendees will be invited to submit their questions.

Sylvan Schefler

Sylvan Schefler, Moderator

Vice Chairman and Investment Banker, Tiger Financial Partners

Rana Gujral

Rana Gujral

CEO, Behavioral Signals

Mike Noonen

Mike Noonen

CEO, MixComm

Dan Slagen

Dan Slagen

CMO, ClimaCell

Jack Tawil

Jack Tawil

CEO, Medpod

Medical Panel Sessions

Technology, Society & Health

Kristie Kuhl, J.D.

Kristie Kuhl, J.D., Moderator

Managing Partner, Finn Partners

Tania Yuki

Tania Yuki

Founder & CEO, Sharablee

Seth Haberman

Seth Haberman

CEO, Sense Education

John Kelly, PhD

John Kelly, PhD

Founder & CEO, Graphika

Satish Rath, MD

Satish Rath, MD

Group Chief of Innovation & Research, Aster DM Healthcare

Medical Technology, Date & Healthcare Transformation

Levi Shaprio

Levi Shaprio

Founder, mHealth Israel

Jonathan Goldstein

Jonathan Goldstein

Director, Boston Scientific Corporation

Jeremy Sohn

Jeremy Sohn

VP, Head of Digital Business Development & Licensing, Novartis

Kevin Tracey, MD

Kevin Tracey, MD

Executive Vice President, Research, Northwell Health

John Whyte, MD, MPH

John Whyte, MD, MPH

Chief Medical Officer, WebMD

Avi Yaron

Avi Yaron

Executive Chairman, Healthya Ventures Lab

 

Nobel Laureate Speaker

 Prof. Ada. Yonath will be speaking on The Genetic Code Translation Machinery as a Therapeutical Target.

Ada Yonath, PhD

Ada Yonath, PhD

Director, Weizmann Institute, Israel